TGFB1 and cancer: In the early stages of cancer, the activated PI3K/AKT pathway antagonizes TGF-β/Smad induced the cytostatic or apoptosis response, whereas, in advanced cancers, both two pathways synergistically cooperate in promoting the invasiveness of cancer cells [97].